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ABSTRACT
Introduction: Several studies have shown that ventricular dysfunction is increased in individuals with diabetes. 
Insulin resistance (IR) may precede type 2 diabetes, and is a pathogenic factor for it. Furthermore, IR has been 
shown to be an independent predictor of cardiovascular disease in diabetes. Given that glucose intolerance and 
IR precede the development of overt diabetes, these factors would be associated with abnormal myocardial 
performance. Aim of the Work: To evaluate the state of left ventricular structure and function in prediabetic 
adults in relation with IR. Patients and Methods: A case–control study was performed. One hundred and 
twenty-one consecutive adults with prediabetes were enrolled for the study. Forty-two of the adults had  IR 
(group A) and 79 had insulin sensitivity (group B). Forty-three healthy (with normal blood glucose) adults 
matched for age and gender were considered as a control group. All groups were subjected to full medical 
history and clinical examination and biochemical and echocardiographic studies. Results: There were no 
statistically significant differences between the insulin-sensitive prediabetic group and the control group in all 
parameters of left ventricular structure and systolic and diastolic functions. Significant differences were observed 
between group A and control group in the  parameters of left ventricular diastolic function (both isovolumetric 
relaxation time and E/A ratio). Regarding correlation between the parameters of diastolic function and different 
variables of IR prediabetic group, there was a statistically significant coefficient correlation with HOMA IR, 
waist circumference and triglycerides. No correlation was observed with fasting glucose, Hb A1c, body mass 
index, blood pressure (BP) and total lipids. Conclusion: In prediabetic adults, IR is associated with impaired 
left ventricular diastolic function, and this association appears to be independent of BP, ventricular geometry, 
glucose tolerance status, total plasma lipids and obesity.
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INTRODUCTION
Diabetes mellitus, hypertension, dyslipidemia, obesity and 
aging are associated with a high risk of cardiovascular 
disease (CVD) as well as other clinical conditions.[1] The 
mechanisms through which cardiovascular risk is increased 
are partially understood. Several distinct pathologic 
processes may initiate myocyte injury, ventricular dilatation 
and myocardial dysfunction in patients with diabetes. The 
common pathways involve neurohumoral, cytokines, 
immune factors, oxidative stress and the accumulation of 
advanced glycosylation end products (AGE) leading to 
protein cross-linking.[2-4]
Echocardiography has introduced the possibility to 
evaluate not only systolic but also diastolic function. 
Left ventricular systolic dysfunction reduces the ejection 
fraction and ejection time and prolongs the isovolumetric 
contraction time. On the other hand, left ventricular 
diastolic dysfunction increases the isovolumetric relaxation 
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time and modifies the timing of diastolic filling.[5,6]
Several studies have shown that ventricular dysfunction 
is increased in individuals with type 2 diabetes. Insulin 
resistance (IR) may precede diabetes by a decade or more, 
and is a pathogenic factor for it.[7] Furthermore, IR has 
been shown to be an independent predictor of CVD in 
diabetes.[8]
Given that glucose intolerance and IR precede the 
development of overt diabetes, these factors would 
be associated with abnormal myocardial performance. 
To investigate this hypothesis, the current study was 
undertaken to evaluate the state of left ventricular structure 
and function in prediabetic adults in relation with IR.
PATIENTS AND METHODS
Patient selection
A case–control study was performed. One hundred twenty-
one consecutive adults with prediabetes were enrolled 
for the study. All the patients were recruited from the 
outpatient diabetes and general medicine clinics of Suez 
Canal University Hospital from February 2009 to May 
2010. Forty-three healthy (with normal blood glucose) 
adults matched for age and gender were considered as the 
control group.
Exclusion criteria included the following: hypertension, 
diabetes mellitus, chronic kidney disease, CVD, severe 
obesity (body mass index [BMI] >40 kg/m2), heavy 
smokers and aged adults (over 60 years old).
All groups were subjected to full medical history and clinical 
examination, including blood pressure (BP), BMI, systemic 
examination and biochemical and echocardiographic 
studies. The BMI was calculated as weight/height2 
(kg/m2) and was used as an estimate of the overall   
adiposity.[9] Waist circumference, a validated estimate of 
visceral adiposity, was measured to the nearest 0.5 cm. 
Central obesity is defined as waist circumference >102 cm 
in males and >88 cm in females.[10]
Diabetes was diagnosed according to the American 
Diabetes Association (ADA) criteria. Blood was drawn 
after fasting for 8 h. A fasting blood sugar (FBG) level 
below 100 mg/dL or glycosylated hemoglobin (Hb A1c) 
<5.7% is considered normal. A FBG level between 100 and 
126 mg/dL or Hb A1c 5.7–6.5% confirms the presence 
of prediabetes and FBG more than 126 mg/dL or Hb 
A1c >6.5% confirms the presence of diabetes in two 
separate occasions.[11] A Homeostasis model of insulin 
resistance (HOMA IR) was used as a measure of IR. It 
was assessed according to the level of fasting glucose and 
insulin, which were measured with a dextran–charcoal 
radioimmunoassay. Serum intact pro-insulin was measured 
by using a highly specific, two-site monoclonal antibody-
based immunoradiometric assay.[12]
The formula for the HOMA IR model is as follows:
HOMA IR = (Fasting insulin mU/mL X Fasting glucose 
mmol/L) / 22.5
Prediabetic adults were divided by their IR status at 
baseline (HOMA IR above and below a median of 2.7) to 
IR (group A) and insulin sensitive (group B), respectively. 
The median was based on the overall nondiabetic control 
group at baseline.
Echocardiographic studies were performed with a 
Hewlett-Packard phased array (Sonos 1800, USA made, 
model: DR 53 15) ultrasonoscope using a 2.5 and 3.5 
MHz transducer. Measurements of ventricular septum, 
posterior wall and left ventricular cavity were performed 
according to the American Society of Echocardiography 
criteria. Left ventricular mass was calculated from the left 
ventricular end-diastolic cavity and septal and posterior wall 
thickness were calculated using the Penn convention and 
the American Society of Echocardiography guidelines. Left 
ventricular mass index (LVMI) was determined as the ratio 
of left ventricular mass in grams to the body surface area 
in square meters. The relative wall thickness (RWT) was 
measured at the end-diastole as the ratio of posterior wall 
thickness plus septal thickness divided by left ventricular 
internal dimension. The transmitral flow velocity profile 
was recorded from the apical four-chamber view with the 
pulsed wave Doppler sample volume positioned at the 
tips of mitral leaflets during diastole. The left ventricular 
outflow velocity pattern was recorded from the apical long 
axis view, with the pulsed wave Doppler sample volume 
positioned just below the aortic valve. Five consecutive 
beats were measured and averaged for each measurement. 
From the mitral inflow signal, we measured the E velocity 
(E), the A velocity (A) and the E/A ratio. The isovolumetric 
relaxation time (IVRT) was measured with the pulsed wave 
sample volume placed between the mitral inflow and the 
left ventricular outflow tract.[13-15]
Ethical consideration: Informed consent was obtained 
from all the adults. The aim and the value of the work were 
explained in a simplified manner for them. No harm was 
inflicted on them. On the contrary, all had benefits of the 25 Journal of Cardiovascular Disease Research Vol. 2 / No 1
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follow-up and the final results of the study.
Statistical analysis
The data were coded and organized. The final study results 
were stated using the SPSS program version 14. Results 
were presented through tables. Student-t, correlation 
coefficient and Chi-square tests were used to evaluate the 
results. Chi-square test was used for qualitative variables 
while independent t-test was used for quantitative variables. 
Correlation analysis was performed using Pearson’s test. 
Statistical significance was considered at a P-value <0.05 
and highly significant at a P-value <0.001.
RESULTS
The baseline characteristics of 121 (65 males and 56 
females) prediabetic adults, mean age 47.8 years, with and 
without IR versus 43 controls (23 males and 20 females), 
mean age 48.6 years, are shown in Table 1. 34.7% of 
the prediabetic adults had IR (group A) and 65.3% had 
insulin sensitivity (group B). No significant differences 
were observed between both the prediabetic adult and 
the control groups regarding BMI, waist circumference, 
BP and plasma lipids. Except waist circumference, all the 
mentioned parameters were nearly similar in both the male 
and the female prediabetic adults.
Echocardiographic and Doppler examination is shown in 
Table 2. There were no statistically significant differences 
between the insulin-sensitive prediabetic and control groups 
in all parameters of left ventricular structure and systolic and 
diastolic functions. On the other hand, significant differences 
were observed between the group with IR and the control 
group in the parameters of left ventricular diastolic function 
(both IVRT and E/A ratio). Comparing echo parameters 
between groups A and B, no significant differences were 
observed except in the E/A ratio.
Correlation between the parameters of diastolic function 
and different variables of IR prediabetic group is shown 
in Table 3. There was a statistically significant coefficient 
correlation with HOMA IR, waist circumference and 
triglycerides. No correlation was observed with FBG, Hb 
A1c, BMI, BP and total lipids.
DISCUSSION
Several studies have demonstrated left ventricular 
diastolic dysfunction to represent the first manifestation 
of myocardial involvement in diabetes. The dysfunction 
represents the earliest pre-clinical manifestation 
of diabetic cardiomyopathy, preceding systolic   
dysfunction.[16,17] Furthermore, the dysfunction can 
precede the development of diabetes,[18] suggesting that 
it is not exclusively a complication of diabetes but rather 
a coexisting condition. The development of diabetic 
Table 1: Clinical and biochemical studies (mean values) of both the case and the control groups
Variables Control group 
N = 43
Prediabetic (case) P-value
All Group A Group B P P* P**
N = 121 N = 42 N = 79
Age (years) 48.6 ± 8.3 47.8 ± 8.3 49.5 ± 7.4 47.3 ± 6.9 n.s n.s n.s
Gender
Male 23 (53%) 65 (54%) 24 (57%) 41 (52%) n s n.s n.s
Fem ale 20 (47%) 56 (46%) 18 (43%) 38 (48%) n.s n.s n.s
SBP (mmHg) 122.3 ± 9.2 121.4 ± 6.5 123.5 ± 4.7 121.6 ± 5.7 n.s n.s n.s
DBP (mmHg) 75.5 ± 3.2  78.4 ± 4.8 79.3 ± 6.2 77.4 ± 4.9 n.s n.s n.s
BMI (%) 26.2 ± 5.4 28.6 ± 5.6 29.4 ± 6.9 27.1 ± 4.6 n.s n.s n.s
W. circum. (cm) 98.4 ± 2.7  103.3 ± 4.5 107.6 ± 3.9 101.4 ± 3.7 <0.01 n.s <0.05
Total lipids (mg/dL) 489.7 ± 36.3 509.3 ± 44.2 520.7 ± 38.4 501.5 ± 28.8 n.s n.s n.s
Triglyceride (mg/
dL)
145.9 ± 18.4 189.6 ± 16.6 193.2 ± 13.4 186.3 ± 17.2 <0.01 <0.05 <0.05
HDL-c (mg/dL) 48.5 ± 2.8 47.2 ± 2.2 45.3 ± 2.9 47.9 ± 4.2 n.s n.s n.s
LDL-c (mg/dL) 121.9 ± 16.3 132.1 ± 17.2 136.3 ± 18.2 131.1 ± 13.9 n.s n.s n.s
FBG (mg/dL) 83.9 ± 11.2 117.8 ± 6.6 119.1 ± 3.2 110.9 ± 11.2 <0.01 <0.01 <0.01
Hb A1c (%) 4.9 ± 0.9  6.1 ± 0.2 6.2 ± 2.1 5.9 ± 0.3 <0.05 <0.05 <0.05
HOMA IR 2.7 ± 0.1 3.9 ± 1.9 5.3 ± 1.9 2.5 ± 1.4 <0.01 n.s <0.05
Group A = Prediabetic adult with insulin resistance, Group B = Prediabetic adult with insulin sensitive, BMI = Body mass index, SBP = Systolic blood pressure, DBP = Diastolic BP, 
N = Number of cases, n.s. = Non significant, FBS = Fasting blood glucose, W. circum. = Waist circumference, HDL-c = High-density lipoprotein cholesterol, LDL-c = Low-density 
lipoprotein cholesterol, Hb A1c = Glycosylated hemoglobin, P = Comparison between group A and control.  P* = Comparison between group B and control, P** = Comparison 
between all prediabetic adults and control group.26 Journal of Cardiovascular Disease Research Vol. 2 / No 1
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All Group A Group B P P* P**
N = 121 N = 42 N = 79
End SD (mm) 27.9 ± 1.5 28.2 ± 1.5 28.5 ± 1.3 27.9 ± 1.9 n.s. n.s. n.s.
End DD (mm) 48.4 ± 3.9 49.1 ± 2.9 49.3 ± 2.1 48.2 ± 3.1 n.s. n.s. n.s.
EF% 63.8 ± 7.1 62.4 ± 6.2 61.6 ± 4.2 64.1 ± 6.9 n.s. n.s. n.s.
IVS thickness (mm) 8.2 ± 0.7 8.1 ± 0.5 80.2 ± 0.8 82.1 ± 0.3 n.s. n.s. n.s.
PW thickness (mm) 8.1 ± 0.9 8.2 ± 0.7 8.8 ± 0.3 7.9 ± 0.2 n.s. n.s. n.s.
RWT% 35.3 ± 3.4 34.9 ± 4.1 36.1 ± 2.8   33.9 ± 2.8 n.s. n.s. n.s.
LVMI (gm/m2) 89.9 ± 7.2 91.2 ± 6.9 92.2 ± 8.1 89.2 ± 0.9 n.s.  n.s. n.s.
IVRT (ms)  91.3 ± 11.2 96.2 ± 9.1 99.9 ± 4.2 92.1 ± 8.4 <0.01 n.s. n.s.
E/A ratio 1.5 ± 0.6 1.4 ± 0.7 1.2 ± 0.2 1.5 ± 0.8 <0.01 n.s. n.s.
Group A = Prediabetic adults with insulin resistance, Group B = Prediabetic adult, SD = Systolic diameter, DD = Diastolic diameter, EF = Ejection fraction, IVS = Interventricular 
septum, PW = Posterior wall, RWT = Relative wall thickness, LVMI = Left ventricular mass index, E = E velocity, A = A velocity, E/A = E/A ratio, IVRT = Isovolumetric relaxation time, 
N = Number of cases, n.s. = Non significant, P = Comparison between group A and control, P* = Comparison between group B and control, P** = Comparison between group A and B
Table 3: Correlation coefficient between diastolic function parameters and different variables in group A
IVRT E/A ratio
Variables r value P-value r value P-value
Age (years) 0.23 n.s. 0.32 n.s.
SBP (mmHg) 0.34 n.s. 0.29 n.s.
DBP (mmHg) 0.41 n.s. 0.43 n.s.
Total lipid (mg/dL) 0.51  n.s. 0.53 n.s.
HDL-c (mg/dL) 0.21  n.s. 0.22 n.s.
LDL-c (mg/dL) 0.28  n.s. 0.25 n.s.
Triglycerides (mg/dL) 0.71 <0.01 0.75 <0.01
BMI% 0.38   n.s. 0.42 n.s.
W. circum. (cm) 0.72 <0.01 0.75 <0.01
FBG (mg/dL)  0.33 n.s. 0.46 n.s.
Hb A1c% 0.42 n.s. 0.41 n.s.
HOMA IR 0.83 <0.001 0.82 <0.001
Group A = Prediabetic adult with insulin resistance, E = E velocity, A = A velocity, E/A = E/A ratio, IVRT = Isovolumetric relaxation time, BMI = Body mass index, SBP = Systolic 
blood pressure, DBP = Diastolic BP, N = Number of cases, n.s. = Non significant, FBS = Fasting blood glucose, W. circum. = Waist circumference    HDL-c = High-density lipoprotein 
cholesterol, LDL-c = Low-density lipoprotein cholesterol, Hb A1c = Glycosylated hemoglobin
myocardial dysfunction is likely multifactorial, with putative 
mechanisms including metabolic disturbance, changes in 
the extracellular matrix components, small vessel disease, 
autonomic dysfunction and IR. Due to cardio-metabolic 
repercussions of hyperglycemia, a detailed evaluation of 
cardiovascular changes in prediabetic and diabetic patients 
is recommended. Furthermore, two recent studies, the 
“ADVANCE” trial[19-20] and the “ACCORD” trial,[21,22] 
reported no significant benefit from intensive HbA1c 
lowering in terms of cardiovascular outcomes in subjects 
with long-standing diabetes. Therefore, we speculate that an 
early intervention is necessary. To our knowledge, the state 
of myocardial performance in prediabetes has received little 
attention. We therefore studied prediabetic normotensive 
adults in whom the prevalence of IR and impaired glucose 
tolerance is high to test the hypotheses that IR is associated 
with impaired cardiac function and that this relationship 
is dependent or independent of glucose tolerance status.
The main finding of the current study is that IR is 
associated with impaired left ventricular diastolic function 
and that the association appears to be independent of BP, 
ventricular geometry, glucose tolerance status, total plasma 
lipids and obesity.
The E/A ratio exhibited a stepwise decrease from the 
control to the prediabetic to the IR groups, primarily 
a result of increased A-wave velocity. The isovolumic 
relaxation time was significantly longer in the IR group. 
These findings suggest that there is a progressive 
impairment in left ventricular relaxation depending on 
the insulin sensitivity and increasing burden of IR on 
myocardial function. Our results are consistent with that 
of a recently published study in patients without overt 
type 2 diabetes.[23] In addition, the diastolic changes were 27 Journal of Cardiovascular Disease Research Vol. 2 / No 1
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associated with an unaltered geometric pattern and a non-
significant depressed systolic function in all groups. These 
different findings indicate that the functional changes 
are independent and precede the systolic and structural 
changes. Our observation is consistent with those of prior 
studies in the fields of obesity,[24] metabolic syndrome[25] 
and diabetes.[26]
The mechanism underlying the relationship between IR 
and myocardial performance is not clear, and the current 
cross-sectional study cannot identify the causative factor. 
Studies have shown that IR states are associated with 
decreased endothelium-dependent vasodilation.[27,28] 
In addition, insulin has been shown to induce vascular 
smooth muscle proliferation and migration in cell   
culture.[29] Hyperglycemia has been shown to lead to the 
formation of AGEs. Therefore, It has been suggested 
that individuals with prediabetes may have decreased 
ventricular function due to prolonged exposure to elevated 
glucose levels.[3,18] Results from the present study did not 
identify impaired left ventricular performance among 
individuals with insulin-sensitive prediabetes. Furthermore, 
no correlation was found between the performance and 
either fasting glucose or Hb A1c measurements. Our data 
suggest that IR may be more important in the development 
of diastolic dysfunction than accumulation of AGEs.
Previous studies have shown that visceral fat in healthy 
individuals is associated with impaired left ventricular 
function.[24,30] The present study confirms this association. 
In agreement with a recent study by Wilfried et al.,[23] we 
observed that abdominal adiposity, as measured by waist 
circumference, was significantly and adversely associated 
with diastolic function, whereas BMI as a measure of 
general adiposity was not. In addition, we found that IR 
appears to be more strongly associated with dysfunction 
than with measures of obesity. These results suggest 
that the obesity–diastolic dysfunction relationship may 
be mediated in part through increasing IR. Obesity, 
especially central abdominal obesity, is associated 
with the secretion of inflammatory cytokines and   
proteins.[31] Another study demonstrated an association 
between inflammatory markers and functional cardiac 
outcomes in patients with a first uncomplicated myocardial 
infarction. Stress hyperglycemia amplifies the inflammatory 
immune reaction and worsens the functional cardiac 
outcomes.[32] In general, adipocytes, in particular from 
the visceral abdominal regions, produce several bioactive 
peptides that in turn impact on vascular structure and 
function.[33,34]
However, increased BP tends to reduce the myocardial 
performance.[1,27,35] Nevertheless, in our study, as all subjects 
were normotensive, such an association was not found.
We should point out that the total lipids had an insignificant 
correlation with ventricular dysfunction. When the 
components of the lipids were considered separately, 
diastolic dysfunction showed direct associations only with 
triglycerides. These results are consistent with those of Lisa 
et al. They reported that triglycerides are independently 
associated with the E/A ratio.[36]
In conclusion, we have shown that prediabetic subjects 
have an impaired left ventricular diastolic function, 
which represent a major pattern of CVD, and these 
changes are predominantly observed in prediabetic 
subjects with increased HOMA IR and visceral obesity. 
None of the studied prediabetic adults had history of 
cardiac complications. Subsequently, the data of the 
current study suggest that as changes can be detected 
before the appearance of clinically apparent heart failure, 
echocardiographic assessment for all prediabetics, especially 
those with IR or those who are obese, is recommended 
as the primary prevention for the development of future 
CVD. Because the functional changes in the prediabetic 
state are limited to subjects with IR, the use of insulin-
sensitizing agents to prevent diabetes could have a 
beneficial effect on CVD. It is likely that over the next few 
years, the measurement of IR will become an increasingly 
important part of the process of risk assessment, and 
may possibly also improve the monitoring of therapy. 
Additional studies will be needed to assess the impact of IR 
on ventricular elasticity and the effect of an improvement 
in insulin sensitivity to improve myocardial performance.
It is imperative to note several limitations in this study 
design. First, the relatively small sample size. Second, this 
study enrolled individuals carefully screened to exclude 
diabetes and hypertension. Further research will be needed 
to confirm whether these results generalize to the general 
population, more insulin-sensitive individuals and those 
with hypertension through a large community-based study.
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